Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-001378-97Phase 3Completed
Phase 3, open-label, single-arm trial of Numeta, sponsored by Baxter International Inc. Primary endpoint: Safety performance. Started Jun 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-001378-97.